David Prosser
- Indexed articles, last 90 days
- 2
- Latest publication
- Jul 10, 2026
- Outlet visibility, for MoneyWeek
- Top 500K sites
- Earliest in this view
- Jul 5, 2026
Latest articles
The future looks bright for biotechnology companies – investments to buy (opens the original)
Read excerpt
Good news for shareholders in the International Biotechnology Trust: their fund has a significant holding in US cancer research business Nuvalent, for which GSK has just agreed to pay $10.6 billion– 40% more than its share price prior to the deal being announced. Even better: Nuvalent is the sixth company in the portfolio to have been acquired at a premium this year. The deals are part of a spree of merger and acquisition (M&A) activity taking place in the global biotechnology sector – to the be
How asset finance can help your company grow (opens the original)
Read excerpt
Asset finance can make more sense than a bank loan for a small business – but seek advice before signing on, says David Prosser
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 500K sites
For MoneyWeek, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.